Leap Therapeutics, Inc.

Home » Leap Therapeutics, Inc.

Secondary

Leap Therapeutics, Inc.

Leap Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells.

Symbol

LPTX

Last Closing Price
$7.50

Shares
1,800,000

Anticipated Date
TBD

Underwriters
Raymond James, Ladenburg Thalmann

To view the prospectus for Leap Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253